Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by therivercardon Apr 18, 2020 1:36pm
223 Views
Post# 30925509

Canopy Rivers undervalued, worth a careful look!

Canopy Rivers undervalued, worth a careful look!
How much is Canopy Rivers undervalued?
River’s management indicated they are...  “With our strong cash position, launching the NCIB gives us the flexibility to purchase back our stock....we continue to have a robust deal pipeline and maintain our focus on making investments that we believe will generate value for our shareholders...
The NCIB allows the Company to purchase up to 10,409,961 subordinated voting shares (the "Subordinated Voting Shares") of the Company (representing 10% of the Company's current public float.
 
So undervalued in relation to their future growth,  $3.50 IPO, a.t.h. $7.75, p.p. $4.80..., analysts current target range to $4.25.  With the support for global regulation, medical breakthroughs, unlimited consumer/pet products, Canopy/Constellation partnership, unique business model, is it possible  not only to revisit but to exceed past milestones?  At .83$cdn s.p. it is worth considering! GLTA

https://www.canopyrivers.com/news/canopy-rivers-news/canopy-rivers-announces-launch-of-normal-course-issuer-bid
Bullboard Posts